| Literature DB >> 28265368 |
Gideon O Oladipo1, Emmanuel O Ibukun1.
Abstract
Cold and immobilization stressors can generate oxidative stress as well as skeletal muscle fatigue. Free radicals cause oxidative degradation of lipids, proteins, nucleic acids, and carbohydrates molecules thereby compromising cell integrity and function. Coturnix japonica (quail) egg had been described as being very functional biochemically, due to the essential biomolecules it contains in very regulated quantity. This study was designed to evaluate the in vitro antioxidant activity of extracts of quail egg yolk and the albumen. The assessment of the antioxidant potentials was typified using the total antioxidant capacity, and ABTS, DPPH (1-diphenyl-2-picrylhydrazyl) and hydroxyl radicals scavenging activities. Others are reducing power, metal chelating and lipid peroxidation inhibition activities. The antistress activities of quail egg yolk and albumen were evaluated on hepatopathic enzymes as well as endogenous antioxidant enzymes. The total antioxidant activities of the yolk extract (YE) and the albumen extracts (AE) were, respectively, 186.57 ± 6.441 mg/g and 172 ± 10.690 mg/g AAE (Ascorbic Acid Equivalent). The YE exhibited significant, potent and appreciable antioxidant activities than AE in a concentration-dependent manner. The study confirmed that quail egg yolk contained highly antioxidative bioactive compounds not present in albumen, contributing to its (yolk) overall antioxidant and anti-inflammatory (antistress) properties, thus necessitating their (albumen and yolk) beneficial effects in the management of oxidative and inflammatory conditions.Entities:
Keywords: Antistress; cold‐restraint stress; hepatopathy; immobilization stress; quail egg yolk and albumen
Year: 2016 PMID: 28265368 PMCID: PMC5332265 DOI: 10.1002/fsn3.397
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 2.863
Total antioxidant (mg/g AAE)
| Extracts | Total antioxidant (mg/g AAE) |
|---|---|
| Yolk | 186.57 ± 6.441a |
| Albumen | 172.04 ± 10.690a |
Values are expressed as mean ± standard deviation (n = 3). Values with different superscript are significantly different (P < 0.05). AAE, Ascorbic Acid Equivalent.
Reducing power activities of extracts of yolk and albumen
| CONC (mg/ml) | Ascorbic acid | Yolk | Albumen |
|---|---|---|---|
| 1 | 1.37 ± 0.025g | 0.48 ± 0.032c | 0.2 ± 0.002c |
| 2 | 1.85 ± 0.013i | 0.65 ± 0.02d | 0.21 ± 0.009c |
| 3 | 2.31 ± 0.011j | 0.78 ± 0.018e | 0.20 ± 0.008c |
| 4 | 2.38 ± 0.032k | 0.92 ± 0.026f | 0.36 ± 0.002b |
| 5 | 3.26 ± 0.03l | 1.44 ± 0.111h | 0.39 ± 0.035b |
Values are expressed as mean ± standard deviation (n = 3). Values with different superscript are significantly different (P < 0.05).
DPPH radical scavenging activities of extracts of yolk and albumen
| CONC (mg/ml) | Ascorbic acid | Yolk | Albumen |
|---|---|---|---|
| 1 | 83.55 ± 1.09e | 88.86 ± 0.27g | 22.25 ± 0.1a |
| 2 | 87.57 ± 1.18f | 89.61 ± 0.23gh | 26.27 ± 0.58b |
| 3 | 90.63 ± 0.27hi | 89.74 ± 0.07gh | 36.39 ± 0.86c |
| 4 | 91.92 ± 0.99ij | 94.43 ± 0.08kl | 51.19 ± 1.06d |
| 5 | 93.02 ± 0.59jk | 95.61 ± 0.14l | 50.33 ± 2.3d |
Values are expressed as mean ± standard deviation (n = 3). Values with different superscript are significantly different (P < 0.05).
2,2'‐azino‐bis‐(3‐ethylbenzothiazoline‐6‐sulfonic acid (ABTS) radical scavenging activities of extracts of yolk and albumen
| CONC (mg/ml) | Trolox | Yolk | Albumen |
|---|---|---|---|
| 1 | 48.33 ± 0.13a | 75.81 ± 0.43e | 67.96 ± 0.34b |
| 2 | 74.69 ± 0.41d | 79.11 ± 0.87g | 73.15 ± 0.90c |
| 3 | 79.08 ± 0.35g | 85.32 ± 0.95j | 77.26 ± 0.35f |
| 4 | 86.43 ± 0.11k | 92.89 ± 0.47m | 82.15 ± 0.64h |
| 5 | 89.31 ± 0.08l | 97.15 ± 0.44n | 84.15 ± 0.66i |
Values are expressed as mean ± standard deviation (n = 3). Values with different superscript are significantly different (P < 0.05).
Metal chelating activities of extracts of yolk and albumen
| CONC (mg/mL) | EDTA | Yolk | Albumen |
|---|---|---|---|
| 1 | 67.25 ± 0.04h | 35.52 ± 0.22d | 22.91 ± 0.06a |
| 2 | 75.5 ± 0.12i | 47.52 ± 0.26e | 25.81 ± 0.05b |
| 3 | 79.67 ± 0.11k | 56.21 ± 0.11f | 26.07 ± 0.12b |
| 4 | 84.35 ± 0.17l | 64.51 ± 0.23g | 26.56 ± 0.19c |
| 5 | 95.62 ± 0.16m | 77.47 ± 0.25j | 35.75 ± 0.08d |
Values are expressed as mean ± standard deviation (n = 3). Values with different superscript are significantly different (P < 0.05).
Hydroxyl radical scavenging activities of extracts of yolk and albumen
| CONC (mg/ml) | Mannitol | Yolk | Albumen |
|---|---|---|---|
| 1 | 68.22 ± 0.08d | 53.21 ± 0.02c | 32.57 ± 0.18a |
| 2 | 76.37 ± 0.06f | 74.69 ± 0.07e | 46.46 ± 0.36b |
| 3 | 92.26 ± 0.12h | 94.32 ± 0.2i | 87.68 ± 0.06g |
| 4 | 95.54 ± 0.09j | 96.51 ± 0.07k | 94.86 ± 1.39ij |
| 5 | 97.51 ± 0.15l | 97.81 ± 0.06l | 91.86 ± 0.77h |
Values are expressed as mean ± standard deviation (n = 3). Values with different superscript are significantly different (P < 0.05).
Lipid peroxidation inhibition activities of extracts of yolk and albumen
| CONC (mg/ml) | Quercetin | Yolk | Albumen |
|---|---|---|---|
| 1 | 64.75 ± 0.53d | 57.52 ± 0.51c | 34.89 ± 0.48a |
| 2 | 73.48 ± 0.29g | 65.97 ± 0.67e | 46.19 ± 0.29b |
| 3 | 81.59 ± 0.14i | 73.73 ± 0.42g | 56.97 ± 0.55c |
| 4 | 87.32 ± 0.38j | 78.93 ± 0.52h | 66.59 ± 0.27e |
| 5 | 92.25 ± 0.12l | 88.69 ± 0.33k | 68.86 ± 0.28f |
Values are expressed as mean ± standard deviation (n = 3). Values with different superscript are significantly different (P < 0.05).
Results of biochemical effects of yolk and albumen on serum
| GRPS | GSH (mg/g tissue) | ALT (U/L) | TOTAL BILIRUBIN (mg/dl) | AST (U/L) | ALP (U/L) | TOTAL PROTEIN (mg/dl) | SOD ( | GSH‐Px ( | CATALASE ( | GGT (U/L) | GST ( |
|---|---|---|---|---|---|---|---|---|---|---|---|
| C‐ | 51.19 ± 4.01e | 18.26 ± 4.55a | 1.15 ± 0.08ab | 36.37 ± 3.71a | 34.28 ± 0.93a | 17.05 ± 0.81e | 149.89 ±4.34g | 44.59 ± 2.92e | 90.46 ± 1.83e | 12.61 ± 0.42a | 5.42 ± 0.79d |
| C+ | 12.846 ± 0.65a | 30.25 ± 1.09d | 3.38 ± 0.12e | 55.97 ± 5.89e | 68.80 ± 0.94d | 3.31 ± 0.89a | 38.6 ± 4.47a | 12.00 ± 1.12a | 26.83 ± 1.42a | 44.83 ± 0.02f | 0.45 ± 0.13a |
| D1 | 20.182 ± 1.20b | 24.22 ± 4.26bc | 1.36 ± 0.15bc | 44.28 ± 1.74cd | 36.02 ± 2.14ab | 12.83 ± 0.30d | 76.154 ± 5.48c | 20.19 ± 2.52c | 37.5 ± 3.09b | 21.52 ± 0.82d | 1.40 ± 0.27b |
| D2 | 31.124 ± 0.76d | 21.67 ± 1.81ab | 1.03 ± 0.19a | 40.43 ± 1.50abc | 35.73 ± 0.84ab | 12.9 ± 0.33d | 109.89 ± 8.34f | 26.68 ± 1.52d | 78.33 ± 1.54d | 14.98 ± 0.62b | 2.78 ± 0.45c |
| A1 | 18.11 ± 2.41b | 26.77 ± 2.64cd | 1.02 ± 0.05a | 45.47 ± 3.81d | 40.12 ± 0.93c | 5.49 ± 0.21b | 57.622 ± 5.27b | 14.86 ± 1.92b | 29.15 ± 1.81a | 27.37 ± 0.82e | 1.63 ± 0.47a |
| A2 | 24.702 ± 1.15c | 24.81 ± 1.86bc | 1.36 ± 0.03bc | 42.32 ± 2.16bcd | 37.8 ± 1.78b | 8.36 ± 0.66c | 84.686 ± 6.01d | 19.35 ± 1.22c | 47.09 ± 1.35c | 21.17 ± 0.12d | 1.63 ± 0.49b |
| Y1 | 23.02 ± 2.25c | 20.93 ± 2.56ab | 1.65 ± 0.24d | 39.30 ± 2.03ab | 40.35 ± 1.22c | 4.94 ± 0.67b | 88.634 ± 2.91d | 20.89 ± 1.72c | 45.29 ± 6.94c | 20.28 ± 0.52c | 1.67 ± 0.26b |
| Y2 | 28.996 ± 2.36d | 18.95 ± 1.84a | 1.53 ± 0.26cd | 37.96 ± 3.18ab | 37.16 ± 2.92b | 8.66 ± 0.55c | 96.694 ± 4.17e | 24.75 ± 2.42d | 74.48 ± 7.79d | 14.30 ± 0.82b | 2.74 ± 0.10c |
Values are expressed as mean ± standard deviation (n = 5). Values with different superscript are significantly different (P < 0.05) for each assay.
ALP, Assay of alkaline phosphatase; ALT, Assay of alanine amino transferase; AST, Assay of aspartate amino transferase; GGT, gamma‐glutamyl transferase; GSH; Reduced glutathione; GST, Glutathione‐S‐transferase; SOD, Superoxide dismutase.